REQUEST A DEMO
Total
USD $0.00
Search more companies

Gensu Pharma Ilac A.S. (Turkiye)

Main Activities: Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers
Full name: Gensu Pharma Ilac Sanayi Ve Ticaret Anonim Sirketi Profile Updated: January 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Gensu Pharma Ilac A.S. is a company based in Turkiye, with its head office in Istanbul. It operates in the Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers industry. The enterprise was incorporated on February 01, 2013. 10 (2023) employees currently work for Gensu Pharma Ilac A.S.. In its most recent financial highlights, the company reported a net sales revenue increase of 93.96% in 2022. During that time, Gensu Pharma Ilac A.S.’s total assets grew by 134.22%. The net profit margin of Gensu Pharma Ilac A.S. increased by 13.97% in 2022.

Headquarters
Metroport Apartmani B-1107 No:14 Bahcelievler Mahallesi D-100 Yanyol Sokak Bahcelievler
Istanbul; Marmara; Postal Code: 34180

Contact Details: Purchase the Gensu Pharma Ilac A.S. report to view the information.

Website: http://www.gensupharma.com.tr

Basic Information
Total Employees:
Purchase the Gensu Pharma Ilac A.S. report to view the information.
Outstanding Shares:
Purchase the Gensu Pharma Ilac A.S. report to view the information.
Incorporation Date:
February 01, 2013
Key Executives
Purchase this report to view the information.
Chairman
Company Performance
Financial values in the chart are available after Gensu Pharma Ilac A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TRY. Absolute financial data is included in the purchased report.
Net sales revenue
93.96%
Total operating revenue
93.96%
Operating profit (EBIT)
197.47%
Net Profit (Loss) for the Period
89.67%
Total assets
134.22%
Total equity
-3.07%
Operating Profit Margin (ROS)
1.12%
Net Profit Margin
13.97%
Return on Equity (ROE)
-26.72%
Debt to Equity Ratio
-22.43%
Quick Ratio
0.14%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?